Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
Mikael KoponenAki S HavulinnaAnnukka MarjamaaAnnukka M TuiskulaVeikko SalomaaPäivi J Laitinen-ForsblomKirsi PiippoLauri ToivonenKimmo KontulaMatti ViitasaloHeikki SwanPublished in: BMC medical genetics (2018)
LQT2 (compared to LQT1), female gender, a cardiac event before age 18, and long QT interval increased the risk of cardiac events in LQTS patients aged 18 to 40 years. The nature of the underlying mutation may be associated with risk variation in both LQT1 and LQT2. The identification of high-risk and low-risk mutations may enhance risk stratification.